Literature DB >> 25242737

Eslicarbazepine and the enhancement of slow inactivation of voltage-gated sodium channels: a comparison with carbamazepine, oxcarbazepine and lacosamide.

Simon Hebeisen1, Nuno Pires2, Ana I Loureiro2, Maria João Bonifácio2, Nuno Palma2, Andrew Whyment3, David Spanswick4, Patrício Soares-da-Silva5.   

Abstract

This study aimed at evaluating the effects of eslicarbazepine, carbamazepine (CBZ), oxcarbazepine (OXC) and lacosamide (LCM) on the fast and slow inactivated states of voltage-gated sodium channels (VGSC). The anti-epileptiform activity was evaluated in mouse isolated hippocampal slices. The anticonvulsant effects were evaluated in MES and the 6-Hz psychomotor tests. The whole-cell patch-clamp technique was used to investigate the effects of eslicarbazepine, CBZ, OXC and LCM on sodium channels endogenously expressed in N1E-115 mouse neuroblastoma cells. CBZ and eslicarbazepine exhibit similar concentration dependent suppression of epileptiform activity in hippocampal slices. In N1E-115 mouse neuroblastoma cells, at a concentration of 250 μM, the voltage dependence of the fast inactivation was not influenced by eslicarbazepine, whereas LCM, CBZ and OXC shifted the V0.5 value (mV) by -4.8, -12.0 and -16.6, respectively. Eslicarbazepine- and LCM-treated fast-inactivated channels recovered similarly to control conditions, whereas CBZ- and OXC-treated channels required longer pulses to recover. CBZ, eslicarbazepine and LCM shifted the voltage dependence of the slow inactivation (V0.5, mV) by -4.6, -31.2 and -53.3, respectively. For eslicarbazepine, LCM, CBZ and OXC, the affinity to the slow inactivated state was 5.9, 10.4, 1.7 and 1.8 times higher than to the channels in the resting state, respectively. In conclusion, eslicarbazepine did not share with CBZ and OXC the ability to alter fast inactivation of VGSC. Both eslicarbazepine and LCM reduce VGSC availability through enhancement of slow inactivation, but LCM demonstrated higher interaction with VGSC in the resting state and with fast inactivation gating.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Carbamazepine; Eslicarbazepine; Fast inactivation; Lacosamide; Oxcarbazepine; Slow inactivation; Voltage-gated sodium channel

Mesh:

Substances:

Year:  2014        PMID: 25242737     DOI: 10.1016/j.neuropharm.2014.09.008

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  35 in total

Review 1.  Tolerability and Safety of Commonly Used Antiepileptic Drugs in Adolescents and Adults: A Clinician's Overview.

Authors:  Martin J Brodie
Journal:  CNS Drugs       Date:  2017-02       Impact factor: 5.749

Review 2.  Pharmacological Treatment of Drug-Resistant Epilepsy in Adults: a Practical Guide.

Authors:  Martin J Brodie
Journal:  Curr Neurol Neurosci Rep       Date:  2016-09       Impact factor: 5.081

3.  Understanding Sodium Channel Function and Modulation Using Atomistic Simulations of Bacterial Channel Structures.

Authors:  C Boiteux; T W Allen
Journal:  Curr Top Membr       Date:  2016-07-29       Impact factor: 3.049

Review 4.  Sodium Channel Blockers in the Treatment of Epilepsy.

Authors:  Martin J Brodie
Journal:  CNS Drugs       Date:  2017-07       Impact factor: 5.749

Review 5.  A review of the efficacy and safety of eslicarbazepine acetate in the management of partial-onset seizures.

Authors:  Rodrigo Rocamora
Journal:  Ther Adv Neurol Disord       Date:  2015-07       Impact factor: 6.570

6.  [Anticonvulsant add-on therapy with Eslicarbazepine acetate : Results of the EPOS-study in adults in Germany].

Authors:  F-P Losch; M Holtkamp; R McMurray; D Lendemans; E Kockelmann
Journal:  Nervenarzt       Date:  2016-10       Impact factor: 1.214

7.  Lacosamide Inhibition of Nav1.7 Voltage-Gated Sodium Channels: Slow Binding to Fast-Inactivated States.

Authors:  Sooyeon Jo; Bruce P Bean
Journal:  Mol Pharmacol       Date:  2017-01-24       Impact factor: 4.436

Review 8.  A Review of the New Antiepileptic Drugs for Focal-Onset Seizures in Pediatrics: Role of Extrapolation.

Authors:  Alexis Arzimanoglou; O'Neill D'Cruz; Douglas Nordli; Shlomo Shinnar; Gregory L Holmes
Journal:  Paediatr Drugs       Date:  2018-06       Impact factor: 3.022

Review 9.  Practical Use of Newer Antiepileptic Drugs as Adjunctive Therapy in Focal Epilepsy.

Authors:  Martin J Brodie
Journal:  CNS Drugs       Date:  2015-11       Impact factor: 5.749

10.  Genetics of Paroxysmal Dyskinesia: Novel Variants Corroborate the Role of KCNA1 in Paroxysmal Dyskinesia and Highlight the Diverse Phenotypic Spectrum of KCNA1- and SLC2A1-Related Disorders.

Authors:  Josua Kegele; Johanna Krüger; Mahmoud Koko; Lara Lange; Ana Victoria Marco Hernandez; Francisco Martinez; Alexander Münchau; Holger Lerche; Stephan Lauxmann
Journal:  Front Neurol       Date:  2021-07-08       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.